Abdul Rahman Al Owais, Minister of Health and Prevention, said the findings of studies during the final stages of phase III clinical trials show that the vaccine is effective and has a strong response, generating antibodies to the virus.

"The vaccine’s safety have been reviewed and results show it is safe for use," the minister added during a press briefing.

Dr Nawal Al-Kaabi, Chairperson of the National Clinical Committee for Coronavirus and the principal investigator of the third phase of clinical trials of the inactive vaccine to combat COVID-19, spoke in detail about the vaccine at the briefing.